RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)
Clinical trial NCT04567550 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04567550
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-20
- Primary completion
- 2026-06-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.